Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
Clinical trial NCT00426361 · COMPLETED
Trial details
- NCT number
- NCT00426361
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-13
- Primary completion
- 2008-03-17
- Enrollment
- 751
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.